For the Inventor, By the Inventor

Enter assignee name

Branford, CT, United States of America

Neurogen Corporation

USPTO Granted Patents = 305

% Expired Patents = 31.5

CIPO Patents = 2

EPO Patents = 4

Forward Citations = 2,351

Loading Chart...

Loading Chart...

121 inventors (with patents filed for the assignee):

Alan J Hutchison (103 out of 128 patents)

Jun Yuan (86 out of 110 patents)

Andrew Y Thurkauf (63 out of 77 patents)

4. Pamela Ann Albaugh (53 out of 65 patents)

5. Kenneth Shaw (38 out of 52 patents)

6. George D Maynard (36 out of 65 patents)

7. Xi Chen (29 out of 34 patents)

8. Raymond F Horvath (28 out of 30 patents)

9. Charles A Blum (28 out of 39 patents)

10. John M Peterson (25 out of 26 patents)

11. Robert W DeSimone (25 out of 34 patents)

12. Xiao-shu He (20 out of 20 patents)

13. Guolin Cai (19 out of 30 patents)

14. Taeyoung Yoon (18 out of 22 patents)

15. Gang Liu (17 out of 66 patents)

Core Competencies:

C5a Receptor Modulators

GABA Receptor Ligands

Melanin Concentrating Hormone

Pyrimidine Derivatives

Piperazine Analogues

Quinazolin-4-ylamine

Imidazole Derivatives

Biaryl Compounds

Dopamine Receptor Ligands

Heterocyclic Compounds

Neurokinin Receptor Ligands

Capsaicin Receptor Ligands

305 patents: Sort by Forward Citations

1. 8759361 - 2-phenoxy pyrimidinone analogues (2014-06-24),

2. 8334382 - Substituted biaryl piperazinyl-pyridine analogues (2012-12-18),

3. 8003656 - 2-phenoxy pyrimidinone analogues (2011-08-23),

4. 7935702 - Substituted biaryl quinolin-4-ylamine analogues (2011-05-03),

5. 7851474 - Dipiperazinyl ketones and related analogues (2010-12-14),

6. 7795262 - Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues (2010-09-14),

7. 7728009 - Thiazole amides, imidazole amides and related analogues (2010-06-01),

8. 7662830 - Substituted biaryl piperazinyl-pyridine analogues (2010-02-16),

9. 7642267 - Benzimidazole and pyridylimidazole derivatives (2010-01-05),

10. 7566712 - Biaryl piperazinyl-pyridine analogues (2009-07-28),

11. 7488740 - Substituted quinolin-4-ylamine analogues (2009-02-10),

12. 7482350 - 4,5-disubstituted-2-aryl pyrimidines (2009-01-27),

13. 7432275 - Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators (2008-10-07),

14. 7371752 - Aryl fused substituted 4-oxy-pyridines (2008-05-13),

15. 7351826 - Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds (2008-04-01),

Neurogen Corporation is a leading biotechnology company that specializes in developing innovative therapies for neurological disorders. With a strong focus on neurology, the company aims to improve the lives of patients by discovering and commercializing groundbreaking treatments. Neurogen's research and development efforts are centered around novel drug discovery, precision medicines, and advanced technologies. Through strategic partnerships and collaborations, Neurogen seeks to transform the field of neurology by bringing cutting-edge therapeutics to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Neurogen Corporation

305 Patents

#1 in Branford, CT

#42 in Connecticut

#1,434 in US

#2,925 in the World

Branford, CT, United States of America

Neurogen Corporation

Forward Citations = 2,351

121 inventors:

Alan J Hutchison (103 out of 128 patents)

Jun Yuan (86 out of 110 patents)

Andrew Y Thurkauf (63 out of 77 patents)

4. Pamela Ann Albaugh (53 out of 65 patents)

5. Kenneth Shaw (38 out of 52 patents)

Please report any incorrect information to [email protected]

Loading…